Congress sets date for hearing on Allergan-tribe deal
06-11-2017
Tribe ‘outraged’ at bill seeking to revoke IPR immunity
06-10-2017
Is the Allergan patent deal a misuse of sovereign immunity?
19-09-2017
uschools / iStockphoto.com
A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Allergan, Saint Mohawk Tribe, Restasis, patent, patent agreement, Native Americans, eye treatment, inter partes review, sovereign immunity, Mylan
